‘Lively’ debate anticipated during CX Vascular Access and Renal Interventions session
A dedicated all-day session at CX 2025 (Wednesday 23 April, Auditorium 3) will address critical challenges in vascular access and renal interventions, featuring multiple...
Tipping the scales with less weight: Why RCTs can be overly burdensome for de...
Ellen Dillavou (WakeMed Heart Center, Raleigh, USA) asks whether the high bar for evidence being sought to bring new de novo devices to market...
LINC 2025: Next-generation pAVF devices
Robert Shahverdyan (Hamburg, Germany) writes for Renal Interventions on the technologies shaping the future of the field of percutaneous arteriovenous fistula (AVF) creation for...
APOL1 gene variants increase the risk of CKD in Africans and descendants, research suggests
New research conducted by the National Institutes of Health (NIH) funded H3Africa Kidney Disease Research Network (H3AKDRN)—co-led by Dwomoa Adu (University of Ghana, Accra,...
